Trans-Atlantic private equity healthcare specialist ArchiMed has made the first exit from its MED II fund with the sale of Austria-based medical technology company EUROLyser to Antech Diagnostics, a provider…
Trans-Atlantic private equity healthcare specialist ArchiMed has made the first exit from its MED II fund with the sale of Austria-based medical technology company EUROLyser to Antech Diagnostics, a provider…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


